Physician profile
Irfan M Altafullah
NPI 1437103629
$203,170.71
in general payments reported to CMS, 2019-2025
19 companies · $43K in 2025
The $43K reported for 2025 was more than what 96% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43K · 2020: $17K · 2021: $25K · 2022: $24K · 2023: $26K · 2024: $24K · 2025: $43K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $94K · Food and Beverage: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $93,998.00 |
| Food and Beverage | $105.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $175,827.07 | 2019-2025 | Amplatzer Amulet, Navitor, Vantageview |
| Mivi Neuroscience, INC. | $12,700.00 | 2021-2023 | |
| Alexion Pharmaceuticals, INC. | $4,920.00 | 2019 | |
| Biosense Webster, INC. | $4,837.50 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $1,762.50 | 2025 | |
| Genentech, INC. | $1,380.00 | 2022 | |
| Biogen, INC. | $930.00 | 2020 | |
| Medtronic, INC. | $400.00 | 2025 | Onyx 18 |
| Intrafusion Gp, LLC | $145.86 | 2021 | |
| W. L. Gore & Associates, INC. | $74.07 | 2023 | Gore Cardioform Septal Occluder |
| Silk Road Medical, INC. | $57.14 | 2020 | |
| Ge Healthcare | $34.68 | 2019 | |
| Sunovion Pharmaceuticals INC. | $32.98 | 2020 | |
| United Imaging Healthcare North America LLC | $25.00 | 2020 | |
| Catalyst Pharmaceuticals, INC. | $17.45 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $13.48 | 2023 | |
| Genentech USA, INC. | $12.98 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irfan Altafullah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.